Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Research Briefing
  • Published:

Combining compact human protein domains with CRISPR systems for robust gene activation

Here we developed synthetic transactivation domains (TADs) built from human mechanosensitive transcription factors (MTFs). By linking MTF TAD segments together, we engineered compact and potent multipartite transcriptional activation modules. We then harnessed these modules to create a CRISPR activation system, which we termed the dCas9 recruited enhanced activation module (CRISPR-DREAM).

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Potent gene activation using CRISPR-DREAM and an all-in-one AAV CRISPRa tool.

References

  1. Gilbert, L. A. et al. CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes. Cell 154, 442–451 (2013). This article was one of the first studies to demonstrate CRISPR-mediated transcriptional regulation in human cells.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Wang, K. et al. Systematic comparison of CRISPR-based transcriptional activators uncovers gene-regulatory features of enhancer-promoter interactions. Nucleic Acids Res. 50, 7842–7855 (2022). This article compared the expression levels and relative efficacies of different state-of-the-art CRISPRa tools in human cells.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Weuring, W. J. et al. CRISPRa-mediated upregulation of scn1laa during early development causes epileptiform activity and dCas9-associated toxicity. CRISPR J. 4, 575–582 (2021). This article demonstrates that some CRISPRa tools can be toxic in some contexts.

    Article  PubMed  Google Scholar 

  4. Konermann, S. et al. Genome-scale transcriptional activation by an engineered CRISPR–Cas9 complex. Nature 517, 583–588 (2015). In this article, the authors developed the potent and widely used SAM CRISPRa tool.

    Article  CAS  PubMed  Google Scholar 

  5. Chavez, A. et al. Highly efficient Cas9-mediated transcriptional programming. Nat. Methods 12, 326–328 (2015). In this article, the authors developed the potent and widely used dCas9–VPR tool.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This is a summary of: Mahata, B. et al. Compact engineered human mechanosensitive transactivation modules enable potent and versatile synthetic transcriptional control. Nat. Methods https://doi.org/10.1038/s41592-023-02036-1 (2023).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Combining compact human protein domains with CRISPR systems for robust gene activation. Nat Methods 20, 1635–1636 (2023). https://doi.org/10.1038/s41592-023-02038-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41592-023-02038-z

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing